Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × NSCLC × Liquid Biopsy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 2 Stomach Neoplasms 1 Neuroendocrine Tumors 1 NSCLC 1 Lung Neoplasms 1 Gallbladder Neoplasms 1 Cholangiocarcinoma 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

osimertinib 2 Vinorelbine 2 HMPL-013 2 Gefitinib 2 tislelizumab 1 sulindac sulfone 1 rezivertinib 1 anlotinib 1 Radiotherapy 1 Platinum 1 Pemetrexed 1 Paclitaxel 1 Liquid Biopsy 1 Gemcitabine 1 Cisplatin 1 Cetuximab 1 Carboplatin 1 CP protocol 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02890849 2024-02-23

RadImm01

Xinqiao Hospital of Chongqing

Phase NA Completed

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡